Similar articles

• Cardiogenic shock: therapeutic implications of altered myocardial energy balance.

  Kones RJ. Kones RJ. Angiology. 1974 May;25(5):317-33. doi: 10.1177/000331977402500504. Angiology. 1974. PMID: 4150913 Review. No abstract available.
• Preservation of ischemic myocardium.

  Forrester JS, Chatterjee K. Forrester JS, et al. Adv Cardiol. 1974;11(00):158-0. doi: 10.1159/000395215. Adv Cardiol. 1974. PMID: 4415185 No abstract available.
• What is the role of positive inotropic agents in the treatment of acute myocardial infarction?

  Mason DT, Amsterdam EA, Miller RR, Williams DO. Mason DT, et al. Cardiovasc Clin. 1977;8(1):113-22. Cardiovasc Clin. 1977. PMID: 849585 No abstract available.
• Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration.

  Wei J, Spotnitz HM, Spotnitz WD, Benvenisty AI, Haasler GB, Malm JR, Hoffman BF. Wei J, et al. J Thorac Cardiovasc Surg. 1984 May;87(5):732-42. J Thorac Cardiovasc Surg. 1984. PMID: 6717051
• Power failure in acute myocardial infarction.

  Swan HJ, Forrester JS, Danzig R, Allen HN. Swan HJ, et al. Prog Cardiovasc Dis. 1970 May;12(6):568-600. doi: 10.1016/0033-0620(70)90022-8. Prog Cardiovasc Dis. 1970. PMID: 4915326 Review. No abstract available.